Thomas J. G. Huot
Geschäftsführer bei Calysta, Inc.
Profil
Thomas J.
G.
Huot is currently the Director at Genomatica, Inc. and the Chief Operating Officer at Calysta, Inc. He previously held positions as Director at Cobalt Technologies, Inc., Liquid Light, Inc., Gilead Connecticut, Inc., and Genopole Entreprises (Private Equity).
He also served as Managing Director at VantagePoint Management, Inc. and Analyst at CDP Capital Technology Ventures.
Dr. Huot has an undergraduate degree from the University of London, a doctorate degree from University College London, and an undergraduate degree from Université de Paris XI Paris Sud.
Aktive Positionen von Thomas J. G. Huot
Unternehmen | Position | Beginn |
---|---|---|
Genomatica, Inc.
Genomatica, Inc. BiotechnologyHealth Technology Genomatica, Inc. designs and develops biotechnology products. It offers metabolic engineering for renewable production of commodity chemicals. The company was founded by Bernhard O. Palsson and Christophe H. Schilling in 1998 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 25.08.2011 |
Calysta, Inc.
Calysta, Inc. Agricultural Commodities/MillingProcess Industries Calysta, Inc. provides sustainable industrial products for food and energy security. The firm develops new Biological Gas-to-Liquids and Biological Gas-to-Chemicals technologies using methane, the primary component of natural gas. It’s technology allows conversion of a plentiful energy resource into high value chemicals and transportation fuels. The company was founded in 2012 by Joshua Silverman and Alan Shaw and is headquartered in Menlo Park, CA. | Geschäftsführer | 12.02.2020 |
Ehemalige bekannte Positionen von Thomas J. G. Huot
Unternehmen | Position | Ende |
---|---|---|
CDP Capital Technology Ventures
CDP Capital Technology Ventures Investment ManagersFinance CDP Capital Technology Ventures is a venture capital firm that invests in technology companies. The firm provides funding for companies in various stages of development, from early-stage startups to established businesses. CDP Capital Technology Ventures focuses on companies in the information technology, telecommunications, and life sciences sectors. The firm is a subsidiary of Caisse de dépôt et placement du Québec, one of Canada's largest institutional fund managers, and ultimately controlled by the Province of Québec. | Corporate Officer/Principal | - |
Genopole Entreprises (Private Equity)
Genopole Entreprises (Private Equity) Investment ManagersFinance Genopole Entreprises is the investment division of the French incubation platform Genopole®, which is specialized in genomics and post-genomics, and regroups teaching and research laboratories as well as startup incubation facilities and biotechnology companies. Genopole was founded by regional government entities. Genopole Entreprises is based in Evry on the south side of Paris and manages the G1J-Genopole 1er Jour Ile-de-France regional pre-seed fund (Genopole 1st Day), established in 1999. The firm aims to identify potential biotechnology entrepreneurs within public and private research laboratories. They invest public funds as well as a majority of private capital, both domestic and international. Investors include large corporations, regional government entities, financial institutions and private equity firms. They cooperate with Cap Décisif Management SAS, a Paris-based regional venture capital firm with a generalist approach. | Corporate Officer/Principal | - |
Liquid Light, Inc.
Liquid Light, Inc. Chemicals: Major DiversifiedProcess Industries Liquid Light, Inc. develops and licenses process technology. It also develops catalysts and chemical processes for converting carbon dioxide to industrial chemicals and liquid transportation fuels. The firm specializes in the design of a technology platform that converts carbon dioxide waste into chemical products. It also focuses on leveraging clean domestic sources of energy, such as solar, wind, hydroelectric, and nuclear energy. The firm's catalyst designs are focused on helping chemical companies turn their industrial waste into a profitable source of revenue. The company was founded by Andrew Bocarsly, Narayanappa Sivasankar, Kyle Teamey and Emily Cole in 2008 and is headquartered in Monmouth Junction, NJ. | Direktor/Vorstandsmitglied | - |
Cobalt Technologies, Inc.
Cobalt Technologies, Inc. Chemicals: SpecialtyProcess Industries Cobalt Technologies, Inc. develops, produces and commercializes bio-based chemicals. The firm engages in the creation of biobutanol using various cellulosic feedstocks, which include corn cobs, treetops and limbs and dead pine trees from pine beetles. It extracts fermentable sugars from biomass and converts them directly into bio n-butanol, which is an ingredient in coatings, paints, adhesives, sealants, inks and other solvent products. The company was founded by Pamela Reilly Contag in 2005 and is headquartered in Mountain View, CA. | Direktor/Vorstandsmitglied | - |
Gilead Connecticut, Inc.
Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Thomas J. G. Huot
University of London | Undergraduate Degree |
University College London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 9 |
---|---|
Cobalt Technologies, Inc.
Cobalt Technologies, Inc. Chemicals: SpecialtyProcess Industries Cobalt Technologies, Inc. develops, produces and commercializes bio-based chemicals. The firm engages in the creation of biobutanol using various cellulosic feedstocks, which include corn cobs, treetops and limbs and dead pine trees from pine beetles. It extracts fermentable sugars from biomass and converts them directly into bio n-butanol, which is an ingredient in coatings, paints, adhesives, sealants, inks and other solvent products. The company was founded by Pamela Reilly Contag in 2005 and is headquartered in Mountain View, CA. | Process Industries |
Genomatica, Inc.
Genomatica, Inc. BiotechnologyHealth Technology Genomatica, Inc. designs and develops biotechnology products. It offers metabolic engineering for renewable production of commodity chemicals. The company was founded by Bernhard O. Palsson and Christophe H. Schilling in 1998 and is headquartered in San Diego, CA. | Health Technology |
Liquid Light, Inc.
Liquid Light, Inc. Chemicals: Major DiversifiedProcess Industries Liquid Light, Inc. develops and licenses process technology. It also develops catalysts and chemical processes for converting carbon dioxide to industrial chemicals and liquid transportation fuels. The firm specializes in the design of a technology platform that converts carbon dioxide waste into chemical products. It also focuses on leveraging clean domestic sources of energy, such as solar, wind, hydroelectric, and nuclear energy. The firm's catalyst designs are focused on helping chemical companies turn their industrial waste into a profitable source of revenue. The company was founded by Andrew Bocarsly, Narayanappa Sivasankar, Kyle Teamey and Emily Cole in 2008 and is headquartered in Monmouth Junction, NJ. | Process Industries |
VantagePoint Management, Inc.
VantagePoint Management, Inc. Investment ManagersFinance VantagePoint Management, Inc. (VantagePoint) is a venture capital firm founded in 1996 by Alan Edward Salzman, James D. Marver. The firm is headquartered in Santa Barbara, California with additional office in Beijing, China. | Finance |
Gilead Connecticut, Inc.
Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Health Technology |
Université de Paris XI Paris Sud | Consumer Services |
Genopole Entreprises (Private Equity)
Genopole Entreprises (Private Equity) Investment ManagersFinance Genopole Entreprises is the investment division of the French incubation platform Genopole®, which is specialized in genomics and post-genomics, and regroups teaching and research laboratories as well as startup incubation facilities and biotechnology companies. Genopole was founded by regional government entities. Genopole Entreprises is based in Evry on the south side of Paris and manages the G1J-Genopole 1er Jour Ile-de-France regional pre-seed fund (Genopole 1st Day), established in 1999. The firm aims to identify potential biotechnology entrepreneurs within public and private research laboratories. They invest public funds as well as a majority of private capital, both domestic and international. Investors include large corporations, regional government entities, financial institutions and private equity firms. They cooperate with Cap Décisif Management SAS, a Paris-based regional venture capital firm with a generalist approach. | Finance |
CDP Capital Technology Ventures
CDP Capital Technology Ventures Investment ManagersFinance CDP Capital Technology Ventures is a venture capital firm that invests in technology companies. The firm provides funding for companies in various stages of development, from early-stage startups to established businesses. CDP Capital Technology Ventures focuses on companies in the information technology, telecommunications, and life sciences sectors. The firm is a subsidiary of Caisse de dépôt et placement du Québec, one of Canada's largest institutional fund managers, and ultimately controlled by the Province of Québec. | Finance |
Calysta, Inc.
Calysta, Inc. Agricultural Commodities/MillingProcess Industries Calysta, Inc. provides sustainable industrial products for food and energy security. The firm develops new Biological Gas-to-Liquids and Biological Gas-to-Chemicals technologies using methane, the primary component of natural gas. It’s technology allows conversion of a plentiful energy resource into high value chemicals and transportation fuels. The company was founded in 2012 by Joshua Silverman and Alan Shaw and is headquartered in Menlo Park, CA. | Process Industries |